Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration

Inclusion Criteria: * Male or female at least 50 years of age at Screening visit * ETDRS BCVA letter score of between 50\* and 75\* (Snellen equivalent of 20/100 to 20/32) * Diagnosis of dry AMD * Able to communicate well with the Investigator and able to understand and comply with the requirements of the study * Informed of the nature of this study and has provided written, informed consent in accordance with institutional, local and national regulatory guidelines Exclusion Criteria: * Current or history of neovascular maculopathy * Presence of center involving GA within the central ETDRS 1 mm diameter at Screening * Media opacities, including cataracts, which might interfere with visual acuity or imaging in the study eye(s) * Posterior capsule opacification, which might interfere with visual acuity or imaging in the study eye(s) * Invasive eye surgery (e.g. cataract, capsulotomy) on a qualifying eye within three 3 months prior to Screening * Visually significant disease in any ocular structure apart from dry AMD * Serious medical illness that will prevent the subject from performing study activities * Presence of or history of malignancy within the past 5 years * Presence or history of known light sensitivity to yellow light, red light, or near infrared radiation (NIR), or if they have a history of light activated CNS disorders (e.g. epilepsy, migraine) * History of neurologic condition known to affect visual function * History of drug, alcohol or substance abuse within 3 months prior to Screening * Participation in any other clinical study at time of screening, or has received an investigational drug or treatment with an investigational device within 3 months prior to Screening * In the opinion of the Investigator, is unlikely to comply with the study protocol